164 related articles for article (PubMed ID: 2316555)
1. Empiric antibiotic use--aztreonam as a model.
Levin S
Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555
[TBL] [Abstract][Full Text] [Related]
2. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam.
Tunkel AR; Scheld WM
Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
5. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
Neu HC
Am J Med; 1985 Feb; 78(2A):77-80. PubMed ID: 4038580
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
7. The use of aztreonam in pediatric patients: a review.
Bosso JA; Black PG
Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
[TBL] [Abstract][Full Text] [Related]
8. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
Hellinger WC; Brewer NS
Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
[TBL] [Abstract][Full Text] [Related]
9. The use of aztreonam in serious gram-negative infections.
Smith G; Bunney RG; Farrell ID; Wood MJ
J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam in the management of gram-negative infections in penicillin-allergic patients: a review.
Saxon A
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S124-7; discussion S128-32. PubMed ID: 2682512
[TBL] [Abstract][Full Text] [Related]
11. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
12. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam.
Johnson DH; Cunha BA
Med Clin North Am; 1995 Jul; 79(4):733-43. PubMed ID: 7791420
[TBL] [Abstract][Full Text] [Related]
14. Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients.
Knockaert DC; Dejaeger E; Nestor L; Verbist L; Pelemans W
Age Ageing; 1991 Mar; 20(2):135-9. PubMed ID: 2053504
[TBL] [Abstract][Full Text] [Related]
15. Aztreonam: the first monobactam.
Sykes RB; Bonner DP
Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
[TBL] [Abstract][Full Text] [Related]
16. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam.
Childs SJ; Bodey GP
Pharmacotherapy; 1986; 6(4):138-52. PubMed ID: 3534798
[TBL] [Abstract][Full Text] [Related]
18. A comparison of monobactam antibiotics in surgical infections.
DiPiro JT; Bowden TA
Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycosides, imipenem, and aztreonam.
Johnson JG; Hardin TC
Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
[TBL] [Abstract][Full Text] [Related]
20. Aztreonam activity, pharmacology, and clinical uses.
Neu HC
Am J Med; 1990 Mar; 88(3C):2S-6S; discussion 38S-42S. PubMed ID: 2180293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
